J K Lee1, J Wu2, S Banks3, C Bernick3, M G Massand2, M T Modic2, P Ruggieri2, S E Jones2. 1. From the Imaging Institute (J.K.L., J.W., M.G.M., M.T.M., P.R., S.E.J.) leej13@ccf.org. 2. From the Imaging Institute (J.K.L., J.W., M.G.M., M.T.M., P.R., S.E.J.). 3. Lou Ruvo Center for Brain Health (S.B., C.B.), Cleveland Clinic, Cleveland, Ohio.
Abstract
BACKGROUND AND PURPOSE: Previous studies investigating MR imaging abnormalities among fighters have had small sample sizes. This investigation assessed a large number of fighters using the same conventional sequences on the same scanner. MATERIALS AND METHODS: Conventional 3T MR imaging was used to assess 499 fighters (boxers, mixed martial artists, and martial artists) and 62 controls for nonspecific WM changes, cerebral microhemorrhage, cavum septum pellucidum, and cavum vergae. The lengths of the cavum septum pellucidum and cavum vergae and the ratio of cavum septum pellucidum to the septum pellucidum lengths were assessed. RESULTS: The prevalence of nonspecific WM changes was similar between groups. Fighters had a prevalence of cerebral microhemorrhage (4.2% versus 0% for controls, P = .152). Fighters had a higher prevalence of cavum septum pellucidum versus controls (53.1% versus 17.7%, P < .001) and cavum vergae versus controls (14.4% versus 0%, P < .001). The lengths of the cavum septum pellucidum plus the cavum vergae (P < .001), cavum septum pellucidum (P = .025), and cavum septum pellucidum to the septum pellucidum length ratio (P = .009) were higher in fighters than in controls. The number of fights slightly correlated with cavum septum pellucidum plus cavum vergae length (R = 0.306, P < .001) and cavum septum pellucidum length (R = 0.278, P < .001). When fighters were subdivided into boxers, mixed martial artists, and martial artists, results were similar to those in the whole-group analysis. CONCLUSIONS: This study assessed MR imaging findings in a large cohort demonstrating a significantly increased prevalence of cavum septum pellucidum among fighters. Although cerebral microhemorrhages were higher in fighters than in controls, this finding was not statistically significant, possibly partially due to underpowering of the study.
BACKGROUND AND PURPOSE: Previous studies investigating MR imaging abnormalities among fighters have had small sample sizes. This investigation assessed a large number of fighters using the same conventional sequences on the same scanner. MATERIALS AND METHODS: Conventional 3T MR imaging was used to assess 499 fighters (boxers, mixed martial artists, and martial artists) and 62 controls for nonspecific WM changes, cerebral microhemorrhage, cavum septum pellucidum, and cavum vergae. The lengths of the cavum septum pellucidum and cavum vergae and the ratio of cavum septum pellucidum to the septum pellucidum lengths were assessed. RESULTS: The prevalence of nonspecific WM changes was similar between groups. Fighters had a prevalence of cerebral microhemorrhage (4.2% versus 0% for controls, P = .152). Fighters had a higher prevalence of cavum septum pellucidum versus controls (53.1% versus 17.7%, P < .001) and cavum vergae versus controls (14.4% versus 0%, P < .001). The lengths of the cavum septum pellucidum plus the cavum vergae (P < .001), cavum septum pellucidum (P = .025), and cavum septum pellucidum to the septum pellucidum length ratio (P = .009) were higher in fighters than in controls. The number of fights slightly correlated with cavum septum pellucidum plus cavum vergae length (R = 0.306, P < .001) and cavum septum pellucidum length (R = 0.278, P < .001). When fighters were subdivided into boxers, mixed martial artists, and martial artists, results were similar to those in the whole-group analysis. CONCLUSIONS: This study assessed MR imaging findings in a large cohort demonstrating a significantly increased prevalence of cavum septum pellucidum among fighters. Although cerebral microhemorrhages were higher in fighters than in controls, this finding was not statistically significant, possibly partially due to underpowering of the study.
Authors: B R Shah; J M Holcomb; E M Davenport; C M Lack; J M McDaniel; D M Imphean; Y Xi; D A Rosenbaum; J E Urban; B C Wagner; A K Powers; C T Whitlow; J D Stitzel; J A Maldjian Journal: AJNR Am J Neuroradiol Date: 2020-07 Impact factor: 3.825
Authors: Peter Stanwell; Grant L Iverson; Ryan Van Patten; Rudolph J Castellani; Paul McCrory; Andrew J Gardner Journal: Front Neurol Date: 2022-04-06 Impact factor: 4.086
Authors: Michael L Alosco; Asim Z Mian; Karen Buch; Chad W Farris; Madeline Uretsky; Yorghos Tripodis; Zachary Baucom; Brett Martin; Joseph Palmisano; Christian Puzo; Ting Fang Alvin Ang; Prajakta Joshi; Lee E Goldstein; Rhoda Au; Douglas I Katz; Brigid Dwyer; Daniel H Daneshvar; Christopher Nowinski; Robert C Cantu; Neil W Kowall; Bertrand Russell Huber; Victor E Alvarez; Robert A Stern; Thor D Stein; Ronald J Killiany; Ann C McKee; Jesse Mez Journal: Alzheimers Res Ther Date: 2021-12-07 Impact factor: 6.982